Monochromatic Infrared Photo Energy (MIRE)
DeviceApply Monochromatic Infrared Photo Energy (MIRE) to the affected nerve
NCT Number: NCT03734731
Our purpose for the study is to find safer, less intrusive, better preforming non-addictive products, as an alternative therapy for pain relief and to help alleviate the opioid epidemic ongoing in America today.
Trial opening soon.
Get NotifiedUp to 90 year
All sexes
Interventional
Not applicable
The AASEM nationally Sponsored/ Physicians Clinical Trial Policy CTP (Medicare study) testing results will be concluded by the Principal Investigators (MDs and DOs) of the study at each site authorized to participate by the AASEM, within the highest of scientific mathematical standards, using Pain DX Neural Scan and/or AXON II testing systems, which include amplitude testing certified with Promethius potentiometers, for Small Pain Fiber (SpF) Nerve Conduction Testing, CMS Carrier CPT codes 95904 now 95909 through 95913 units, as needed.
It is expected that, at a later date, other products used for therapy and/or rehabilitation purposes will be added to the comparison protocol for the National Trial Number (NCT# TBA) assigned by the National Library of Medicine (NLM). Other products and/or DME equipment may include: infrared light therapy CPT code 97026, TENS therapy and home units CPT therapy code # 97032, as well as montmorillonite minerals for physical applications (montmorillonite is a natural mineral and has no CPT code - is not a CMS ordinarily payable event).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Apply Monochromatic Infrared Photo Energy (MIRE) to the affected nerve
Apply Transcutaneous Electrical Nerve Stimulation (TENS) to the affected nerve
Prescribe Opioids to treat for pain or circulatory disorders, dosage to be determined by Principal Investigator
Prescribe Cannabis to treat for pain or circulatory disorders, dosage to be determined by Principal Investigator. Comparing Opioid results to Cannabis results with objective nerve testing
Other names: Marijuana
Time frame: 4 to 8 weeks per nerve
To note changes in axon nerve firings obtained by nerve amplitude measurements. Categorize pain and swelling disorders' treatment success or failure, as defined within the AASEM, using the Neural Scan or AXON-II objective nerve conduction testing systems, with objective responses
Contact information is provided by the study sponsor or research team.
Brook Davis
CONTACT
Ronald F Davis
CONTACT
American Association of Sensory Electrodiagnostic Medicine
Industry
Clinical Trial Policy Study for the Objective Comparison of Cannabis Vs Opioids (CVO) Pain Management and Therapy Types for Circulatory and Chronic Pain Issues
Acronym: CVO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740681
Chronic Pain, Neurologic Manifestations
View Trial DetailsNCT07696923
Adhesive Capsulitis, Bursitis
Taipei, Taiwan
View Trial DetailsNCT07641504
Back Pain, Chronic Pain
Birmingham, Alabama, United States
View Trial DetailsNCT07717762
Acute Pain, Chronic Pain
Bern, Canton of Bern, Switzerland
View Trial Details